ERBB2 and breast cancer: Jin et al. have demonstrated that inhibition of FASN by C75 (Table 1) in the breast cancer cell lines SKBR3 and BT474 was responsible for an increase in the internalization and degradation of HER2 associated with a decrease in the level of HER2 mRNA [36].